Medline Inc.

MDLN Healthcare Medical Instruments & Supplies

Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.

Revenue
+14.1%
Free cash flow
+916.1%
Total debt
−23.7%

Quarter to September 2026, against a year earlier

39.96 0.39 −0.97%
Market cap
$52.3B
P/E
58.4×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
2.25
Beneish M
−2.38
Dividend safety
n/a

Medline Inc. 8-K filed Nov 4, 2026

Period ended Nov 4, 2026 · Filed · accepted 7:34 AM ET · Document on sec.gov · Filing index

2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

This 8-K released the latest quarter’s results. Read Earnings & Analysis